Mondésert, E, Schraen-Maschke, S, Quadrio, I, Bousiges, O, Bouvier, D, Delaby, C, Bedel, A, Lehmann, S, Fourier, A. A French multicenter analytical evaluation of the automated Lumipulse G sNfL blood assay (Fujirebio®) and its comparison to four other immunoassays for serum neurofilament light chain assessment in clinical settings. CLINICA CHIMICA ACTA. 2025; 565DOI:10.1016/j.cca.2024.120007. PMID:39454987. IF:2.900(Q1/1D).

Petersen, ME, Flores-Aguilar, L, Head, E, Montoliu-Gaya, L, Strydom, A, Pape, SE, Fortea, J, Ashton, NJ, Udeh-Momoh, C, O'Bryant, SE, German, D, Despa, F, Mapstone, M, Zetterberg, H. Blood biomarkers in Down syndrome: Facilitating Alzheimer's disease detection and monitoring. ALZHEIMERS & DEMENTIA. 2025; 21(1)DOI:10.1002/alz.14364. PMID:39535517. IF:11.100(Q1/1D).

Aldecoa, I, Barroeta, I, Carroll, SL, Fortea, J, Gilmore, A, Ginsberg, SD, Guzman, SJ, Hamlett, ED, Head, E, Perez, SE, Potter, H, Molina-Porcel, L, Raha-Chowdhury, R, Wisniewski, T, Yong, WH, Zaman, S, Ghosh, S, Mufson, EJ, Granholm, AC. Down Syndrome Biobank Consortium: A perspective. ALZHEIMERS & DEMENTIA. 2024; 20(3)DOI:10.1002/alz.13692. PMID:38270275. IF:11.100(Q1/1D).

Vaque-Alcázar, L, Videla, L, Benejam, B, Soriano, LD, Barroeta, I, Fernandez, S, Rodriguez-Baz, I, Arriola-Infante, JE, Arranz, J, Blesa, LM, Sanjuan-Hernández, A, Morcillo-Nieto, AO, Bejanin, A, Arenaza-Urquijo, EM, Lleó, A, Bartres-Faz, D, Carmona-Iragui, M, Fortea, J. Generational effects in Down syndrome: Enriched environment enhances functionality without reducing Alzheimer's disease risk. ALZHEIMERS & DEMENTIA. 2025; 21(10)DOI:10.1002/alz.70447. PMID:41041908. IF:11.100(Q1/1D).